Cencora Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Cencora Inc.
Former names: Amerisourcebergen Corp Amerisource Bergen Corp
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 5122 — Wholesale-Drugs, Proprietaries & Druggists' Sundries
Jurisdiction of incorporation: Delaware
Headquarters city: Conshohocken
Headquarters state / province: Pennsylvania
Headquarters country: United States
Fiscal year end: September
Ticker symbol: COR
Primary stock exchange: NYSE

Identifiers

SEC CIK: 0001140859
EIN: 23-3079390
Wikidata ID: Q470156

Board of directors

Follow this board

Dennis M. Nally · Director
Since 2023
Dermot Mark Durcan · Director
Since 2023
Ellen Cooper · Director
Since 2026
Frank Clyburn · Director
Since 2024
Henry Wadsworth McGee III · Director
Since 2023
Jane E. Henney M.D. · Director
Since 2023
Kathleen W. Hyle · Director
Since 2023
Lauren M. Tyler · Director
Since 2023
Lon R. Greenberg · Director
Since 2023
Lorence H. Kim · Director
Since 2023
Lori Ryerkerk · Director Overboarded
Since 2025
Michael J. Long · Director
Since 2023
Redonda Miller · Director
Since 2023
Richard W. Gochnauer · Director
Since 2023
Robert E. Sanchez · Director
Since 2026
Robert P. Mauch · Director · President & CEO
Since 2024
Steven H. Collis · Director · Executive Chairman
Since 2023
Werner Baumann · Director
Since 2023

Chief executives

Robert P. Mauch · President & CEO

Dates unknown

Steven H. Collis · Chairman, President & CEO

Since July 2011

81 CEO score

Outstanding · grade A

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 50% of the scoring weight is on file.

Dividends 15%: 89
Revenue growth 20%: 79
Earnings growth 15%: 76

50% of the scoring weight is on file. Figures cover September 2010 – September 2025.

Director election results

Annual meeting of March 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 17 other boards. 3 are in the same sector.

Shared director Other board Same sector +1 more in the list below

Revolution Medicines Inc. Same sector
via Frank Clyburn and Lorence H. Kim
Advanced Micro Devices Inc.
via Dermot Mark Durcan
Arrow Electronics Inc.
via Michael J. Long
Bausch + Lomb Corporation Same sector
via Steven H. Collis
Celanese Corporation
via Lori Ryerkerk
Centene Corporation
via Lauren M. Tyler
Eaton Corporation PLC
via Lori Ryerkerk
Elevance Health Inc.
via Steven H. Collis
International Paper Company
via Lori Ryerkerk
Kailera Therapeutics Inc. Same sector
via Frank Clyburn
Lincoln National Corporation
via Ellen Cooper
Mobix Labs Inc.
via Michael J. Long
Morgan Stanley
via Dennis M. Nally
Norfolk Southern Corporation
via Lori Ryerkerk
Ryder System Inc.
via Robert E. Sanchez
Texas Instruments Incorporated
via Robert E. Sanchez
X-Energy Inc.
via Kathleen W. Hyle

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $2,310,427; 3 purchases by 2 insiders
Sold, last 12 months: $15,384,673; 13 sales by 5 insiders

Date	Insider	Transaction	Shares	Price	Value
Nov 6, 2026	Campbell Elizabeth S Officer (Executive Vice President)	Option exercise	+1,830	—	—
Nov 6, 2026	Krikorian Lazarus Officer (SVP & Chief Accounting Officer)	Option exercise	+1,398	—	—
Nov 6, 2026	Robert P. Mauch Director, Officer (President & CEO)	Option exercise	+4,066	—	—
Nov 6, 2026	Campbell Elizabeth S Officer (Executive Vice President)	Shares withheld for tax	−846	$333.56	$282,192
Nov 6, 2026	Krikorian Lazarus Officer (SVP & Chief Accounting Officer)	Shares withheld for tax	−576	$333.56	$192,131
Nov 6, 2026	Robert P. Mauch Director, Officer (President & CEO)	Shares withheld for tax	−1,673	$333.56	$558,046
Nov 2, 2026	Krikorian Lazarus Officer (SVP & Chief Accounting Officer)	Open-market sale	−986	$330.96	$326,327
Oct 30, 2026	Ellen Cooper Director	Grant or award	+91	$330.84	$30,106
Oct 30, 2026	Verma Pawan Officer (EVP, Chief Data & Info Officer)	Option exercise	+8,538	—	—
Oct 30, 2026	Dennis M. Nally Director	Grant or award	+106	$330.84	$35,069
Oct 30, 2026	Lauren M. Tyler Director	Grant or award	+91	$330.84	$30,106
Oct 30, 2026	Verma Pawan Officer (EVP, Chief Data & Info Officer)	Shares withheld for tax	−4,254	$330.84	$1,407,393
Oct 1, 2026	Robert E. Sanchez Director	Grant or award	+275	—	—
Oct 1, 2026	Krikorian Lazarus Officer (SVP & Chief Accounting Officer)	Open-market sale	−986	$303.18	$298,935
Sep 16, 2026	Lon R. Greenberg Director	Open-market sale	−1,280	$321.30	$411,264

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Cencora Inc.

Who is the CEO of Cencora Inc.?

Steven H. Collis has been Cencora Inc.'s Chairman, President & CEO since July 2011.

How many directors are on Cencora Inc.'s board?

Cencora Inc.'s board has 18 directors: Dennis M. Nally, Dermot Mark Durcan, Ellen Cooper, Frank Clyburn, Henry Wadsworth McGee III, Jane E. Henney M.D., Kathleen W. Hyle, Lauren M. Tyler, Lon R. Greenberg, Lorence H. Kim and 8 others.

Are Cencora Inc. insiders buying or selling shares?

Over the last 12 months, Cencora Inc. insiders bought $2.3 million of shares in 3 purchases and sold $15.4 million of shares in 13 sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Cencora Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="cencora-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.